• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presenting on Emerging Growth Conference 90 Day 1 on February 25; Register to live stream

    2/24/26 7:00:00 AM ET
    $AEMD
    $ASPI
    $CLNN
    $CRGO
    Medical/Dental Instruments
    Health Care
    Major Chemicals
    Industrials
    Get the next $AEMD alert in real time by email

    MIAMI, Feb. 24, 2026 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 90th Emerging Growth Conference on February 25 & 26, 2026.

    The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    For updates, follow us on Twitter

    Day 1 - Wednesday

    February 25, 2026

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    ASP Isotopes Inc. (NASDAQ:ASPI)

    Keynote speaker: Paul Elliot Mann, CEO

    9:40 – 10:10

    Evolve Royalties, Ltd. (CSE:EVR)

    Keynote speaker: Joseph de la Plante, Co-Founder & CEO

    10:15 – 10:45

    MetaVia Inc. (NASDAQ:MTVA)

    Keynote speakers: Hyung Heon "HH" Kim, President / CEO, & Marshall H. Woodworth, CFO

    10:50 – 11:20

    First Phosphate Corp. (CSE:PHOS) (OTCQX:FRSPF) (FSE: KD0)

    Keynote speaker: John Passalacqua, CEO

    11:25 – 11:55

    Charbone Hydrogen Corporation (TSXV:CH) (OTCQB:CHHYF)

    Keynote speaker: Benoit Veilleux - CFO

    12:00 – 12:30

    Clean Air Metals, Inc. (OTCQB:CLRMF) (TSXV:AIR) (FRA: CKU)

    Keynote speaker: Mike Garbutt - President & CEO

    12:35 – 1:05

    Aethlon Medical (NASDAQ:AEMD)

    Keynote speaker: Jim Frakes, Acting CEO & CFO and Steven LaRosa, Chief Medical Officer

    1:10 – 1:40

    U.S. Gold Corp. (NASDAQ:USAU)

    Keynote speaker: Luke Anthony Norman, Executive Chairman

    1:45 – 2:15

    Clene Inc., (NASDAQ:CLNN)

    Keynote speakers: Rob Etherington, President / CEO

    2:20 – 2:50

    Heme Solutions, a private company

    Keynote speaker: Jonathan Barkman, Founder



    2:55 – 3:05

    Highland Copper Company Inc. (OTCQB:HDRSF) (TSXV:HI)

    Keynote speaker: Barry O'Shea, CEO



    3:10 – 3:20

    Imagion Biosystems Limited. (CXA: IBX) (ASX: IBX) 

    Keynote speakers: Robert Romeo Proulx, Executive Chairman & Ward Detwiler, Chief Business Officer

    3:25 – 3:35

    Metavista3D Inc., (TSXV:DDD)

    Keynote speaker: Jeffrey R. Carlson, CEO & Director

    3:40 – 3:50

    Regen BioPharma Inc. (OTC:RGBP)

    Keynote speakers: David Koos, President / CEO, & Harry M. Lander, Ph.D. Senior Scientific Consultant



    3:55 – 4:05

    Tiger Gold Corp. (TSXV:TIGR)

    Keynote speaker: Fraser Macdougall, Director



    4:10 – 4:20

    Stallion Uranium Corp. (OTCQB:STLNF) (TSXV:STUD)

    Keynote speaker: Darren Slugoski, VP Exploration



    4:25 – 4:35

    Cobalt Blue Holdings Limited (ASX: COB) (OTC:CBBHF)

    Keynote speaker: Andrew Tong, Chief Executive Officer and Managing Director

    Day 2 – Thursday

    February 26, 2026

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:40 – 10:10

    Freightos, Ltd. (NASDAQ:CRGO)

    Keynote speaker: Ian Arroyo - Chief Strategy Officer

    10:15 – 10:45

    Specificity, Inc. (OTCID: SPTY)

    Keynote speaker: Jason Wood, CEO

    11:25 – 11:55

    IBC Advanced Alloys Corp. (TSXV:IBC) (OTCQB:IAALF)

    Keynote Speaker: Mark Smith, Chairman & CEO



    12:00 – 12:30

    U.S. Energy Corporation (NASDAQ:USEG)

    Keynote speaker: Ryan Smith, President, CEO & Director

    12:35 – 1:05

    Orion Energy Systems, Inc. (NASDAQ:OESX)

    Keynote speaker: Sally Washlow, CEO, and Per Brodin, CFO

    1:10 – 1:40

    Unusual Machines, Inc. (NYSE:UMAC)

    Keynote speaker: Brian Hoffman, CFO

    1:45 – 2:15

    Dr. Phone Fix Canada Corporation (TSXV:DPF) 

    Keynote speakers: Dr. Piyush Sawhney, Founder / CEO, and Anil Kumar Verma, VP Store development

    2:20 – 2:50

    ZenaTech (NASDAQ:ZENA) (FSE: 49Q) (BMV:ZENA)

    Keynote speaker: Linda Montgomery, Vice President, Corporate Development



    3:10 – 3:20

    Phoenix Energy Services Corp. (OTCQB:PHXHF) (TSE: PHX)

    Keynote speaker: Mike Buker, President and CEO

    3:25 – 3:35

    Signature Resources Ltd. (TSXV:SGU) (OTCQB:SGGTF)

    Keynote speaker: Dan Denbow, President, CEO & Director

    3:40 – 3:50

    Metaguest.ai Inc. (OTCQB:MGSTF) (CSE:METG)

    Keynote speaker: Colin Keddy, President

    3:55 – 4:05

    Coelacanth Energy Inc. (OTC:CEIEF) (TSXV:CEI)

    Keynote speaker: Robert J. Zakresky, President & CEO

    4:10 – 4:20

    African Discovery Group, Inc., now Copper Intelligence (OTCID: AFDG)

    Keynote speakers: Alan Kessler, Chairman / Director Copper Intelligence, Andrew Groves, Future Chairman Copper Intelligence & Aldo Cesano Director Copper Intelligence

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    Replays: Subscribe to our YouTube Channel

    About EmergingGrowth.com

    Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.

    About the Emerging Growth Conference

    The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

    All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients.  Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future.  In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

    If you believe or know of a company that might fit our audience, contact us here.

    Thank you for your interest in our conference, and we look forward to your participation in future conferences.

    Contact:

    Emerging Growth

    Phone: 1-305-330-1985

    Email: [email protected]



    Primary Logo

    Get the next $AEMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEMD
    $ASPI
    $CLNN
    $CRGO

    CompanyDatePrice TargetRatingAnalyst
    ASP Isotopes Inc.
    $ASPI
    12/4/2025$13.00Overweight
    Cantor Fitzgerald
    MetaVia Inc.
    $MTVA
    9/4/2025$12.00Buy
    H.C. Wainwright
    Unusual Machines Inc.
    $UMAC
    8/19/2025$15.00Buy
    Needham
    Aethlon Medical Inc.
    $AEMD
    7/7/2025$1.50Neutral
    H.C. Wainwright
    ZenaTech Inc.
    $ZENA
    6/16/2025$9.00Buy
    Maxim Group
    MetaVia Inc.
    $MTVA
    12/30/2024$12.00Buy
    H.C. Wainwright
    U.S. Gold Corp.
    $USAU
    12/18/2024$10.00Buy
    ROTH MKM
    Unusual Machines Inc.
    $UMAC
    12/18/2024$18.00Buy
    Maxim Group
    More analyst ratings

    $AEMD
    $ASPI
    $CLNN
    $CRGO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Mclaughlin Vallerie

    4 - Clene Inc. (0001822791) (Issuer)

    2/20/26 4:05:57 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Director Wilcox Reed N

    4 - Clene Inc. (0001822791) (Issuer)

    2/20/26 4:05:22 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Director Mosca Alison

    4 - Clene Inc. (0001822791) (Issuer)

    2/20/26 4:04:47 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEMD
    $ASPI
    $CLNN
    $CRGO
    SEC Filings

    View All

    Clene Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Clene Inc. (0001822791) (Filer)

    2/24/26 8:01:51 AM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form EFFECT filed by ZenaTech Inc.

    EFFECT - ZenaTech, Inc. (0001997403) (Filer)

    2/24/26 12:15:09 AM ET
    $ZENA
    Computer Software: Prepackaged Software
    Technology

    Aethlon Medical Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - AETHLON MEDICAL INC (0000882291) (Filer)

    2/23/26 4:15:32 PM ET
    $AEMD
    Medical/Dental Instruments
    Health Care

    $AEMD
    $ASPI
    $CLNN
    $CRGO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Matlin David J bought $216,664 worth of shares (33,333 units at $6.50), increasing direct ownership by 7% to 477,824 units (SEC Form 4)

    4 - Clene Inc. (0001822791) (Issuer)

    1/13/26 2:48:54 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Washlow Sally A. bought $299,922 worth of shares (21,166 units at $14.17), increasing direct ownership by 83% to 46,524 units (SEC Form 4)

    4 - ORION ENERGY SYSTEMS, INC. (0001409375) (Issuer)

    11/21/25 4:09:48 PM ET
    $OESX
    Building Products
    Consumer Discretionary

    CEO Smith Ryan Lewis bought $4,560 worth of shares (4,000 units at $1.14), increasing direct ownership by 0.34% to 1,183,039 units (SEC Form 4)

    4 - US ENERGY CORP (0000101594) (Issuer)

    9/15/25 7:00:12 AM ET
    $USEG
    Oil & Gas Production
    Energy

    $AEMD
    $ASPI
    $CLNN
    $CRGO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald initiated coverage on ASP Isotopes with a new price target

    Cantor Fitzgerald initiated coverage of ASP Isotopes with a rating of Overweight and set a new price target of $13.00

    12/4/25 8:40:44 AM ET
    $ASPI
    Major Chemicals
    Industrials

    H.C. Wainwright resumed coverage on MetaVia with a new price target

    H.C. Wainwright resumed coverage of MetaVia with a rating of Buy and set a new price target of $12.00

    9/4/25 9:02:00 AM ET
    $MTVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Needham initiated coverage on Unusual Machines with a new price target

    Needham initiated coverage of Unusual Machines with a rating of Buy and set a new price target of $15.00

    8/19/25 8:37:18 AM ET
    $UMAC
    Radio And Television Broadcasting And Communications Equipment
    Technology

    $AEMD
    $ASPI
    $CLNN
    $CRGO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Shorepower Technologies (OTC: SPEV) Enters Merger Agreement with Aeternum Health LLC and Announces Strategic Transition to Longevity-Focused Healthcare Platform

    HILLSBORO, Ore., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Shorepower Technologies, Inc. (OTC:SPEV) ("Shorepower" or the "Company") today announced that it has entered into an Agreement and Plan of Merger dated February 17, 2026, with Aeternum Health LLC ("Aeternum Health"), pursuant to which Aeternum Health will merge with and into Shorepower, with Shorepower continuing as the surviving entity.Upon completion of the merger, the Company intends to transition its strategic focus from transportation electrification infrastructure to the development of services, products, and solutions designed to increase longevity and optimize health outcomes. Transaction Summary Issuance of common stock represen

    2/24/26 8:30:00 AM ET
    $ASPI
    Major Chemicals
    Industrials

    Clene Issues Stockholder Letter Highlighting Upcoming CNM-Au8® 2026 Catalysts

    Operating capital runway sufficient into the fourth quarter of 2026 In-person Type C FDA meeting scheduled by end of the first quarter of 2026 to discuss the latest CNM-Au8 data submitted in late 2025Anticipated submission of a New Drug Application (NDA) to FDA for CNM-Au8 via an accelerated regulatory pathway in the second quarter of 2026Potential for FDA acceptance of this NDA and issuance of a Prescription Drug User Fee Act (PDUFA) date in the second half of 2026 SALT LAKE CITY, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ:CLNN) (along with its subsidiaries, "Clene" or the "Company") and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical com

    2/24/26 8:00:00 AM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Presenting on Emerging Growth Conference 90 Day 1 on February 25; Register to live stream

    MIAMI, Feb. 24, 2026 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 90th Emerging Growth Conference on February 25 & 26, 2026. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: [email protected] For updates, follow us on Twitter Day 1 - WednesdayFebruary 25, 2026 8:45Virtual Lobby opens.Register for the Conference. If you already registered, go

    2/24/26 7:00:00 AM ET
    $AEMD
    $ASPI
    $CLNN
    Medical/Dental Instruments
    Health Care
    Major Chemicals
    Industrials

    $AEMD
    $ASPI
    $CLNN
    $CRGO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Unusual Machines Inc.

    SC 13G/A - Unusual Machines, Inc. (0001956955) (Subject)

    11/14/24 4:29:47 PM ET
    $UMAC
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Amendment: SEC Form SC 13G/A filed by Clene Inc.

    SC 13G/A - Clene Inc. (0001822791) (Subject)

    11/14/24 3:32:55 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Clene Inc.

    SC 13G - Clene Inc. (0001822791) (Subject)

    11/14/24 3:26:45 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEMD
    $ASPI
    $CLNN
    $CRGO
    Leadership Updates

    Live Leadership Updates

    View All

    Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026

    Aethlon invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation on the Emerging Growth Conference.SAN DIEGO, Feb. 23, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (the Company or Aethlon) (NASDAQ:AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, is pleased to announce that it has been invited to present on the Emerging Growth Conference on February 25, 2026 at 12:30-1:00 PM ET. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's CEO and CFO, Jim Frakes in

    2/23/26 8:01:00 AM ET
    $AEMD
    Medical/Dental Instruments
    Health Care

    Military UAV Sector Forecast to Surpass $40+ Billion as Modern Warfare Evolves

    NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Unmanned aerial vehicles (UAVs), commonly known as drones, have become a transformative technology in modern defense and military operations, reshaping strategies from reconnaissance to precision strike capabilities. Military drones offer armed forces enhanced situational awareness, reduced risk to personnel, and cost-efficient mission profiles across surveillance, target acquisition, logistics, and electronic warfare. As autonomous systems incorporating artificial intelligence and advanced sensor suites continue to mature, they are increasingly integral to networked battlefield operations and force multiplie

    2/19/26 8:30:00 AM ET
    $NOC
    $PRZO
    $UAVS
    Industrial Machinery/Components
    Industrials
    Military/Government/Technical
    Aerospace

    Freightos appoints Michael Netter as CRO to Drive Global Go-to-Market Strategy

    Digital Logistics Expert Brings Proven Logistics Tech Experience to Drive Expansion Across the Freight Ecosystem BARCELONA, Spain, Nov. 10, 2025 /PRNewswire/ -- Freightos Limited (NASDAQ:CRGO), the leading digital freight booking and payment platform for the international freight industry, today announced the appointment of Michael Netter as Chief Revenue Officer (CRO). Netter will lead global revenue strategy, sales excellence and commercial execution. Netter brings deep experience in B2B SaaS, digital logistics, IoT solutions and Go-To-Market leadership. This includes his most recent role as Vice President of Sales EMEA at Proemion, an IoT and Industry 4.0 software company.  Prior to that

    11/10/25 7:00:00 AM ET
    $CRGO
    Integrated Freight & Logistics
    Industrials

    $AEMD
    $ASPI
    $CLNN
    $CRGO
    Financials

    Live finance-specific insights

    View All

    Freightos Reports Fourth Quarter and Full Year 2025 Results

    Fourth Quarter Revenue Up 12% year-over-year, Full Year Revenue Up 24%Year-End Cash of $28M; On track to Breakeven by Year-End 2026BARCELONA, Spain, Feb. 23, 2026 /PRNewswire/ - Freightos Limited (NASDAQ:CRGO), the leading vendor-neutral digital booking and payment platform for the international freight industry, today reported financial results for the quarter and year ended December 31, 2025. "We delivered fourth quarter results in line with guidance. For full year 2025, revenue grew 24%, and although foreign exchange headwinds pressured Adjusted EBITDA from the second quarter onward, our burn rate was unaffected and we ended the year with a cash position that fully funds our plans and ena

    2/23/26 7:00:00 AM ET
    $CRGO
    Integrated Freight & Logistics
    Industrials

    Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update

    Clinical and research programs continue to advance, supported by year-to-date cost efficiencies Conference Call Today at 4:30 p.m. ET SAN DIEGO, Feb. 12, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (the Company or Aethlon) (NASDAQ:AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today reported financial results for its fiscal third quarter ended December 31, 2025, and provided an update on recent developments.  Key Highlights Maintained Nasdaq Listing: Continued compliance with Nasdaq listing requirements, with all prior compliance matters remaining resolved. Clinical Progress: Cohort 2 of the Australian oncology tr

    2/12/26 4:15:00 PM ET
    $AEMD
    Medical/Dental Instruments
    Health Care

    Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2026

    SAN DIEGO, Feb. 4, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that it will issue financial results for its fiscal third quarter ended December 31, 2025, at 4:15 p.m. ET on Thursday, February 12, 2026. Management will host a conference call on Thursday, February 12, 2026, at 4:30 p.m. ET to review financial results and recent corporate developments. Following management's formal remarks, there will be a question and answer session. Interested parties can register for the conference call by navigating to https://dpregister.com/sreg/10206585/1034

    2/4/26 8:01:00 AM ET
    $AEMD
    Medical/Dental Instruments
    Health Care